CLSI’s June 2022 AST Committees Week Meetings will be held 25-28 June at Loews Chicago O’Hare Hotel. There will be nine in-person meetings. Virtual pre-meetings of the Methods Development and Standardization Working Group and Quality Control Working Group are scheduled on Wednesday, 15 June 2022. For the first time, CLSI will be hosting the AST Committees Week Meetings in hybrid format, to accommodate attendees who prefer to participate virtually.

WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


CLSI’s June 2022 AST Committees Week Meetings

6/14/2022

CLSI’s June 2022 AST Committees Week Meetings will be held 25-28 June at Loews Chicago O’Hare Hotel. There will be nine in-person meetings. Virtual pre-meetings of the Methods Development and Standardization Working Group and Quality Control Working Group are scheduled on Wednesday, 15 June 2022.  For the first time, CLSI will be hosting the AST Committees Week Meetings in hybrid format, to accommodate attendees who prefer to participate virtually. Meeting attendance is free—participants can register here. First time attendees can familiarize themselves with CLSI’s AST Committees Week by watching this New Attendee Orientation video.

For all events held during June 2022 AST Meetings, all those attending in person must be fully vaccinated* and must complete an acknowledgement form affirming their vaccinated status, and provide proof of vaccination, as part of the registration process. In-person attendees must also agree to conform to all CDC guidelines, local rules, and other COVID-19 protocols adopted by CLSI and made applicable to any event held during CLSI in person meetings.

At the conclusion of the AST Committees Week, meeting presentations, minutes, and more will be posted here.

CLSI’s AST Subcommittee provides useful information to laboratories, enabling them to advise clinicians in the selection of appropriate antimicrobial therapy. Volunteers for the AST Subcommittee come from microbiology laboratories, government agencies, and pharmaceutical and diagnostic microbiology industries. Together, they focus on the following key elements:

  • Developing standard reference methods for antimicrobial susceptibility tests
  • Providing quality control parameters for standard test methods
  • Establishing interpretive criteria for results of standard antimicrobial susceptibility tests
  • Providing suggestions for testing and reporting strategies that are clinically relevant and cost-effective
  • Continually refining standards and guidelines, thereby optimizing the detection of emerging resistance
  • Educating users through multimedia communication of standards and guidelines
  • Fostering a dialogue with users of these methods and those who apply them

As a result, the interests of the professions, government, and industry remain balanced and aimed at a single common interest—quality medical testing.

*Per CDC, fully vaccinated means a person has received their primary series of COVID-19 vaccines. A person is considered fully vaccinated 2 weeks after completion of a two-dose mRNA series (eg, Moderna, Pfizer) or one dose of Janssen (Johnson & Johnson) vaccine.

 

← Go Back